These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31251818)

  • 1. A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density.
    Brentnall AR; van Veen EM; Harkness EF; Rafiq S; Byers H; Astley SM; Sampson S; Howell A; Newman WG; Cuzick J; Evans DGR
    Int J Cancer; 2020 Apr; 146(8):2122-2129. PubMed ID: 31251818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
    Brentnall AR; Cuzick J; Buist DSM; Bowles EJA
    JAMA Oncol; 2018 Sep; 4(9):e180174. PubMed ID: 29621362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.
    van Veen EM; Brentnall AR; Byers H; Harkness EF; Astley SM; Sampson S; Howell A; Newman WG; Cuzick J; Evans DGR
    JAMA Oncol; 2018 Apr; 4(4):476-482. PubMed ID: 29346471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
    Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
    Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panel.
    Evans DGR; van Veen EM; Harkness EF; Brentnall AR; Astley SM; Byers H; Woodward ER; Sampson S; Southworth J; Howell SJ; Maxwell AJ; Newman WG; Cuzick J; Howell A
    Genet Med; 2022 Jul; 24(7):1485-1494. PubMed ID: 35426792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort.
    Brentnall AR; Harkness EF; Astley SM; Donnelly LS; Stavrinos P; Sampson S; Fox L; Sergeant JC; Harvie MN; Wilson M; Beetles U; Gadde S; Lim Y; Jain A; Bundred S; Barr N; Reece V; Howell A; Cuzick J; Evans DG
    Breast Cancer Res; 2015 Dec; 17(1):147. PubMed ID: 26627479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control study.
    Evans DG; Brentnall A; Byers H; Harkness E; Stavrinos P; Howell A; ; Newman WG; Cuzick J
    J Med Genet; 2017 Feb; 54(2):111-113. PubMed ID: 27794048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer risk prediction using Tyrer-Cuzick algorithm with an 18-SNPs polygenic risk score in a European population with below-average breast cancer incidence.
    Oblak T; Škerl P; Narang BJ; Blagus R; Krajc M; Novaković S; Žgajnar J
    Breast; 2023 Dec; 72():103590. PubMed ID: 37857130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I.
    Warwick J; Birke H; Stone J; Warren RM; Pinney E; Brentnall AR; Duffy SW; Howell A; Cuzick J
    Breast Cancer Res; 2014 Oct; 16(5):451. PubMed ID: 25292294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case-Control Study to Add Volumetric or Clinical Mammographic Density into the Tyrer-Cuzick Breast Cancer Risk Model.
    Brentnall AR; Cohn WF; Knaus WA; Yaffe MJ; Cuzick J; Harvey JA
    J Breast Imaging; 2019 Jun; 1(2):99-106. PubMed ID: 31423486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of five methods of measuring mammographic density: a case-control study.
    Astley SM; Harkness EF; Sergeant JC; Warwick J; Stavrinos P; Warren R; Wilson M; Beetles U; Gadde S; Lim Y; Jain A; Bundred S; Barr N; Reece V; Brentnall AR; Cuzick J; Howell T; Evans DG
    Breast Cancer Res; 2018 Feb; 20(1):10. PubMed ID: 29402289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials.
    Cuzick J; Brentnall AR; Segal C; Byers H; Reuter C; Detre S; Lopez-Knowles E; Sestak I; Howell A; Powles TJ; Newman WG; Dowsett M
    J Clin Oncol; 2017 Mar; 35(7):743-750. PubMed ID: 28029312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density.
    Rudolph A; Fasching PA; Behrens S; Eilber U; Bolla MK; Wang Q; Thompson D; Czene K; Brand JS; Li J; Scott C; Pankratz VS; Brandt K; Hallberg E; Olson JE; Lee A; Beckmann MW; Ekici AB; Haeberle L; Maskarinec G; Le Marchand L; Schumacher F; Milne RL; Knight JA; Apicella C; Southey MC; Kapuscinski MK; Hopper JL; Andrulis IL; Giles GG; Haiman CA; Khaw KT; Luben R; Hall P; Pharoah PD; Couch FJ; Easton DF; Dos-Santos-Silva I; Vachon C; Chang-Claude J
    Breast Cancer Res; 2015 Aug; 17(1):110. PubMed ID: 26275715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion of Endogenous Plasma Dehydroepiandrosterone Sulfate and Mammographic Density in Risk Prediction Models for Breast Cancer.
    Gabrielson M; Ubhayasekera KA; Acharya SR; Franko MA; Eriksson M; Bergquist J; Czene K; Hall P
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):574-581. PubMed ID: 31948996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of polygenic risk scores for prediction of breast cancer and breast cancer subtypes in Chinese women.
    Hou C; Xu B; Hao Y; Yang D; Song H; Li J
    BMC Cancer; 2022 Apr; 22(1):374. PubMed ID: 35395775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry.
    Pal Choudhury P; Brook MN; Hurson AN; Lee A; Mulder CV; Coulson P; Schoemaker MJ; Jones ME; Swerdlow AJ; Chatterjee N; Antoniou AC; Garcia-Closas M
    Breast Cancer Res; 2021 Feb; 23(1):22. PubMed ID: 33588869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative.
    Kurian AW; Hughes E; Simmons T; Bernhisel R; Probst B; Meek S; Caswell-Jin JL; John EM; Lanchbury JS; Slavin TP; Wagner S; Gutin A; Rohan TE; Shadyab AH; Manson JE; Lane D; Chlebowski RT; Stefanick ML
    Cancer; 2021 Oct; 127(20):3742-3750. PubMed ID: 34228814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci.
    Reeves GK; Travis RC; Green J; Bull D; Tipper S; Baker K; Beral V; Peto R; Bell J; Zelenika D; Lathrop M;
    JAMA; 2010 Jul; 304(4):426-34. PubMed ID: 20664043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement.
    Darabi H; Czene K; Zhao W; Liu J; Hall P; Humphreys K
    Breast Cancer Res; 2012 Feb; 14(1):R25. PubMed ID: 22314178
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.